A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers

Clinical trial NCT04710290 · UNKNOWN

Trial details

NCT number: NCT04710290
Sponsor: E-DA Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Metastatic Cancer Chemotherapy

Start date: 2018-01-04
Primary completion: 2021-12-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.